News

Filter

Current filters:

ReproductiveSeasonique

Watson challenges Exelon patent; wins Seasonique appeal; launches generic Kadian

13-11-2011

There was an active day for US generics drugmaker Watson Pharmaceuticals (NYSE: WPI), first, confirming…

ActavisDuramed PharmaceuticalsExelonGenericsKadianMarkets & MarketingNeurologicalNorth AmericaPatentsReproductiveSeasoniqueWatson Pharmaceuticals

Watson debuts generic Seasonique in USA

28-07-2011

US generics major Watson Pharmaceuticals (NYSE: WPI) announced that its subsidiary, Watson Laboratories…

AmethiaDuramed PharmaceuticalsGenericsMarkets & MarketingNorth AmericaReproductiveSeasoniqueTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Watson confirms OxyContin patent challenge; gets favorable Seasonique ruling

28-03-2011

Watson Pharmaceuticals (NYSE: WPI) says that its subsidiaries, Andrx Labs and Watson Laboratories have…

GenericsNeurologicalNorth AmericaOxyContinPatentsPharmaceuticalPurdue PharmaReproductiveSeasoniqueTeva Pharmaceutical IndustriesWatson Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top